ASU Home
ASU A-Z Index
My ASU
Colleges & Schools
Law Directory
Map
Search
:
News & Events
/
Law Library
/
Administration
/
Current Students
/
Prospective Students
Admissions
Centers & Programs
Faculty
Career Services
Alumni and Friends
Support ASU Law
The Sandra Day O'Connor College of Law Faculty Scholarship Repository
A Service of the Ross-Blakley Law Library
Publications for
Gary E. Marchant
New Search
|
Go Back
|
Printable Version
FORTHCOMING AND WORKS IN PROGRESS
Regulatory Toxicology
, in
Casarett & Doull's Toxicology: The Basic Science of Poisons
(Curtis Klaassen, ed., McGraw-Hill Professional) (forthcoming 2012).
Gary E. Marchant & Rachel A. Lindor,
The Coming Collision Between Autonomous Vehicles and the Liability System
,
Santa Clara L. Rev
. (forthcoming 2012)
K23 .A56
BOOKS
Cancer Risk Evaluation: Methods and Trends
(Günter Obe, Burkhard Jandrig, Gary E. Marchant, Holger Schütz, Peter M. Wiedemann, eds., Wiley 2011).
The Growing Gap Between Emerging Technologies and Legal-ethical Oversight: The Pacing Problem
(Gary Marchant, Braden Allenby, & Joseph Herkert, eds., Springer 2011).
T174.5 .G76 2011
Gary Marchant, Guy Cardineau, & Thomas P Redick
,
Thwarting Consumer Choice: The Case Against Mandatory Labeling for Genetically Modified Foods
(AEI Press 2010).
TP374.5 .M36 2010
Genomics and Environmental Regulation: Science, Ethics, and Law
(Richard R. Sharp, Gary Marchant, & Jamie A Grodsky eds., Johns Hopkins University Press 2008).
QH438.7 .G462 2008
Kenneth L. Mossman & Gary E. Marchant
,
Arbitrary and Capricious: the Precautionary Principle in the European Union Courts
(AEI Press 2004).
KJE3666.M37 2004
ARTICLES
Big Issues for Small Stuff: Nanotechnology Regulation and Risk Management
,
52 Jurimetrics J. 243 (2012)
.
K10 .U72
Westlaw
|
Keycite
Gary Marchant, Kenneth Abbot & Elizabeth A. Corley,
Soft Law Oversight Mechanisms for Nanotechnology
,
52 Jurimetrics J. 279 (2012)
.
K10 .U72
Westlaw
|
Keycite
Gary Marchant, Andrew Askland, Brad Biddle, Frank Curci, Timothy Haslach & Lyn Gaudet,
The Expanding Role and Importance of Standards in the Information and Communications Technology Industry
,
52 Jurimetrics J. 177 (2012)
.
K10 .U72
Lexis
|
Westlaw
|
Keycite
|
Shepards
|
Abstract
Gary E. Marchant & Andrew White,
An International Nanoscience Advisory Board to Improve and Harmonize Nanotechnology Oversight
,
13 J. Nanopart. Res. 1489 (2011)
.
RS201.N35 J68
Genetic Susceptibilities: The Future Drive of Ambient Air Quality Standards?
,
43 Ariz. St. L.J. 791 (2011)
.
K1 .R532
Lexis
|
Shepards
Gary E. Marchant, Braden Allenby, Ronald Arkin, Edward T. Barrett, Jason Borenstein, Lyn M. Gaudet, Orde Kittrie, Patrick Lin, George R. Lucas, Richard O’Meara, & Jared Silberman,
International Governance of Autonomous Military Robots
,
12 Colum. Sci. & Tech. L. Rev. 272 (2011)
.
K3
SSRN
Gary E. Marchant, Rachel A. Lindor & Doug E. Campos-Outcalt,
Physician Liability: The Next Big Thing for Personalized Medicine?
,
8 Personalized Medicine 457 (2011)
.
Gary Marchant & Angus Crane,
The Benefits and Challenges of a Voluntary Occupational Exposure Database
,
53 JOEM S52 (2011)
.
Kenneth Abbott, Gary Marchant, & Douglas Sylvester,
A New Soft Law Approach to Nanotechnology Oversight: A Voluntary Product Certification Scheme
,
28 UCLA J. Envtl. L. & Pol'y 123 (2010)
.
K25 .C525
SSRN
|
HeinOnline
|
Lexis
|
Westlaw
|
Keycite
|
Shepards
Kenneth Abbott & Gary Marchant,
Institutionalizing Sustainability Across the Federal Government
,
2 Sustainability 1924 (2010)
.
SSRN
Gary Marchant, Ann Meyer, & Megan Scanlon,
Integrating Social and Ethical Concerns Into Regulatory Decision-Making for Emerging Technologies
,
11 Minn. J. L. Sci. & Tech. 345 (2010)
.
K13 .I5474
Gary Marchant & Lyn Gulley,
National Security Neuroscience and the Reverse Dual-Use Dilemma
,
1 AJOB Neuroscience 22 (2010)
.
QH332
Gary Marchant & Lynda L. Pope,
Forbidding Science?
,
15 Sci. & Engineering Ethics 263 (2009)
.
Abstract
Gary Marchat & Jason Robert,
Genetic Testing for Autism Predisposition: Ethical, Legal, and Social Challenges
,
9 Hous. J. Health L. & Pol'y 203 (2009)
.
K8 .O79
HeinOnline
|
Westlaw
|
Keycite
Douglas Sylvester, Kenneth Abbott, & Gary Marchant,
Not Again! Public Perception, Regulation, and Nanotechnology
,
3 Regulation &Governance 165 (2009)
.
SSRN
Small is Beautiful: What Can Nanotechnology Do for Personalized Medicine?
,
7 Current Pharmacogenomics & Personalized Med. 231 (2009)
.
Abstract
Genomics and Environmental Regulation: Scenarios and Implications
.
Abstract
Kenneth W. Abbott, Gary E. Marchant & Douglas J. Sylvester,
A Framework Convention for Nanotechnology? A Policy Review
,
38 Environ't L. Rep.10507 (2008)
.
KF3775.A6 E5
SSRN
|
Westlaw
|
Keycite
Hormesis and Toxic Torts
,
27 Hum. & Experimental Toxicology 97 (2008)
.
Abstract
Gary E. Marchant, Douglas S. Sylvester & Kenneth Abbott,
Risk Management Principles for Nanotechnology
,
2 Nanoethics 43 (2008)
.
SSRN
Mark Rothstein, Yu Cai, & Gary Marchant,
The Ghost in Our Genes: Legal and Ethical Implications of Epigenetics
,
19 Health Matrix 1 (2008)
.
SSRN
|
HeinOnline
|
Westlaw
|
Keycite
Kenneth Abbott, Gary Marchant, & Douglas Sylvester,
A New Approach to Risk Management for Nanotechnology
.
SSRN
Personalized Medicine and the Law
,
44 Ariz. Att'y 12 (2007)
.
K1.R51
SSRN
|
Lexis
|
Westlaw
|
Keycite
|
Shepards
Douglas Sylvester, Kenneth Abbott, & Gary Marchant,
A Framework Convention for Nanotechnology?
,
36 Envtl. L. Rep. 10931 (2006)
.
KF3775 A6 E5
SSRN
Genetic Data in Toxic Tort Litigation
,
14 J.L. & Pol’y 7 (2006)
.
K10.O8633
SSRN
|
HeinOnline
|
Lexis
|
Shepards
Kenneth Abbott, Sandeep Gopalan, Gary Marchant, & Douglas Sylvester,
International Regulatory Regimes for Nanotechnology
.
SSRN
Gary E Marchant, Robert J Milligan, & Brian Wilhelmi,
Legal Pressures and Incentives for Personalized Medicine
,
3 Personalized Medicine 391 (2006)
.
Gary Marchant & Douglas Sylvester,
Transnational Models for Regulation of Nanotechnology
,
34 J.L. Med. & Ethics 714 (2006)
.
K10.O8644
SSRN
|
HeinOnline
|
Lexis
|
Westlaw
|
Keycite
|
Shepards
Property Rights and Benefit-sharing for DNA Donors?
,
45 Jurimetrics 153 (2005)
.
K10. U721
SSRN
|
HeinOnline
|
Lexis
|
Westlaw
|
Keycite
Michael E. Beren & Gary Marchant,
Genetic Samples and Genetic Philanthropy
,
6 Virtual Mentor (November 2004)
.
Abstract
Cary Coglianese & Gary Marchant,
Shifting Sands: the Limits of Science in Setting Risk Standards
,
152 Penn. L. Rev. 1255 (2004)
.
K25.N6441
SSRN
|
HeinOnline
|
Lexis
|
Westlaw
|
Keycite
|
Shepards
Cary Coglianese & Gary Marchant,
The EPA’s Risky Reasoning
,
27 Regulation 16 (2004)
.
K18 .E32
SSRN
Confidence-Building Measures for Genetically Modified Foods
,
44 Jurimetrics 1 (2003)
.
K10.U721
SSRN
|
HeinOnline
|
Lexis
|
Westlaw
|
Keycite
From General Policy to Legal Rule: The Aspirations and Limitations of the Precautionary Principle
,
111 Envtl. Health Perspect. 1799 (2003)
.
HE 20.3559
Abstract
Genomics and Toxic Substances: Part I - Toxicogenomics
,
33 Envtl. L. Rep. 10071 (2003)
.
KF3775.A6 E5
SSRN
Genomics and Toxic Substances: Part II - Toxicogenetics
,
33 Envtl. Law Rep. 10641 (2003)
.
KF3775.A6 E5
SSRN
Andrew Askland & Gary Marchant,
GM Foods: Potential Public Consultation and Participation Mechanisms
,
44 Jurimetrics 99 (2003)
.
K10.U721
SSRN
|
HeinOnline
|
Lexis
|
Westlaw
|
Keycite
Precaution, Environmental Science, and Preventive Public Policy
,
111 Envtl. Health Perspect. a 492 (2003)
. (book review)
HE 20.3559
Michael A. Amen et al.,
A Synthetic Vitreous Fiber (SVF) Occupational Exposure Database: Implementing the SVF Health and Safety Partnership Program
,
17 Applied Occupational & Env’t. Hygiene 276 (2002)
.
Abstract
Biotechnology and the Precautionary Principle: Right Question, Wrong Answer
,
4 Int. J. Biotech. 34 (2002)
.
Abstract
Legal Criteria and Judicial Precedents Relevant to Incorporation of Hormesis Into Regulatory Decision-Making
,
288 Sci. Total Env’t. 141 (2002)
.
Abstract
The Genome Cometh
,
Chem. Bus. at 12-16 (July/Aug. 2002)
.
Gary Marchant & Kenneth L. Mossman,
The Precautionary Principle and Radiation Protection
,
13 Risk: Health, Safety & Environ't 137 (2002)
.
K22.I281
HeinOnline
|
Abstract
Toxicogenomics and Toxic Torts
,
20 Trends in Biotech. 329 (2002)
.
Abstract
Genetics and Toxic Torts
,
31 Seton Hall L. Rev. 949 (2001)
.
K23.E72
SSRN
|
HeinOnline
|
Lexis
|
Westlaw
|
Keycite
|
Shepards
Genetic Susceptibility and Biomarkers in Toxic Injury Litigation
,
41 Jurimetrics 67 (2000)
.
K10.U721
SSRN
|
HeinOnline
|
Westlaw
|
Keycite
Prof. Michael Baram et al.,
Regulatory and Liability Considerations
,
6 B. U. J. Sci. & Tech. L. 5 (2000)
.
K2. O82655
HeinOnline
|
Lexis
|
Westlaw
|
Keycite
|
Shepards
Turning Two Blind Eyes: The EPA's Failure to Consider Costs and Health Disbenefits in Revising the Ozone Standard
,
11 Tul. Envtl. L. J. 261 (1998)
.
K24.U513
SSRN
|
HeinOnline
|
Lexis
|
Westlaw
|
Keycite
|
Shepards
Gary Marchant & Edward W. Warren,
“More Good Than Harm”: A First Principle for Environmental Agencies and Reviewing Courts
,
20 Ecology L.Q. 379 (1993)
.
K5. C6
SSRN
|
HeinOnline
|
Westlaw
|
Keycite
Freezing Carbon Dioxide Emissions: An Offset Policy for Slowing Global Warming
,
22 Envtl. L. 623 (1992)
.
K5.N823
SSRN
|
HeinOnline
|
Lexis
|
Westlaw
|
Keycite
|
Shepards
Michael S. Baram & Gary Marchant,
The Use of Risk Assessment Evidence to Prove Increased Risk and Alternative Causation in Toxic Tort Litigation
,
41 Fed’n Ins. & Corp. Couns. Q. 95 (1990)
.
K6.E371
SSRN
Dawn P. Danzeisen & Gary Marchant,
Acceptable Risk for Hazardous Air Pollutants
,
13 Harv. Envtl. L. Rev. 535 (1989)
.
K8.A722
HeinOnline
|
Westlaw
|
Keycite
|
Abstract
F. William Brownell et. al.,
Vinyl Chloride: an Opportunity for Rational Decision Making
,
4 Nat. Resources & Env't. 26 (1989)
.
K14.A7371
SSRN
|
HeinOnline
|
Westlaw
|
Keycite
Modified Rules for Modified Bugs: Balancing Safety and Efficiency in the Regulation of Deliberate Release of Genetically Engineered Microorganisms
,
1 Harv. J. L. & Tech. 163 (1988)
.
K8.A7255
SSRN
|
HeinOnline
|
Lexis
|
Shepards
Gary E. Marchant et al.,
Applications and Findings of an Occupational Exposure Database for Synthetic Vitreous Fibers
.
BOOK CHAPTERS
A Return to Expertise?: A Proposal for an Institute of Scientific Assessments
, in
Institutions and Incentives in Regulatory Science
(Jason Scott Johnson, ed., Lexington Books, 2012).
GE180 .I57 2012eb
Gary E. Marchant, Douglas J. Sylvester, Kenneth W. Abbott & Lyn M. Gaudet,
International Harmonization of Nanotechnology Oversight
, in
The Nanotechnology Challenge: Creating Law and Legal Institutions for Uncertain Risks
(David A. Dana, ed., Cambridge University Press, 2012).
Over-Simplified: The Enduring and Unfortunate Legacy of Silent Spring
, in
Silent Spring at 50: The False Crises of Rachel Carson
(Roger Meiners, Pierre Desrochers & Andrew Morriss, eds., Cato Institute 2012).
Gary E. Marchant & Alexandra Lopez,
The (In) Feasibility of Regulating Enhancement
, in
Building Better Humans? Refocusing the Debate on Transhumanism
(Hava Tirosh-Samuelson & Kenneth L. Mossman, eds., Peter Lang 2012).
The Precautionary Principle and Radio Frequency Exposure from Mobile Phones
, in
Cancer Risk Evaluation: Methods and Trends
(Günter Obe, Burkhard Jandrig, Gary Marchant, Holger Schütz, & Peter M. Wiedemann, Wiley 2011).
Kenneth W. Abbott, Lyn Gulley, Gary E. Marchant & Douglas Sylvester,
Transnational Regulation of Nanotechnology: Reality or Romanticism?
, in
International Handbook on Regulating Nanotechnologies
(Graeme Hodge, Diana Bowman & Andrew Maynard, eds., Edward Elgar Pubishers 2011).
SSRN
Science Policy and Cancer Risk Assessment
, in
Cancer Risk Assessment: Chemical Carcinogenesis, Hazard Evaluation, and Risk Quantification
(Ching-Hung Hsu & Todd Stedeford, eds., John Wiley & Sons 2010).
Genomics, Ethics, and Intellectual Property
, in
Intellectual Property Management in Health and Agricultural Innovation: A Handbook of Best Practices
(A. Krattiger, R.T. Mahoney, L Nelsen, et al. eds., MIHR : PIPRA 2007).
K1519 .B54 2007
Abstract
Gary Marchant, Douglas Sylvester, & Kenneth W. Abbott,
Nanotechnology Regulation: The United States Approach
, in
New Global Frontiers of Regulation: The Age of Nanotechnology
(G. Hodge, D. Bowman & K. Ludlow eds., Edward Elgar Publishing 2007).
SSRN
Applications of Biomarkers in Forensics and Toxic Tort Proceedings
, in
Toxicological Biomarkers 273
(Anthony DeCaprio ed., Informa HealthCare 2006).
Abstract
Law, Science, & Technology
, in
Encyclopedia of Science, Technology, and Ethics
(Carl Mitcham ed., Macmillan Reference 2005).
Q175.35 .E53 2005
Genetics and the Future of Environmental Policy
, in
Environmentalism and the Technologies of Tomorrow
(Robert Olsen & David Rejeski eds., Island Press 2004).
HC79.E5 E597 2005
Abstract
Gary E. Marchant & Jamie A. Grodsky,
Genomics and Environmental Justice: Some Preliminary Thoughts
, in
Genomics and Environmental Regulation : Science, Ethics, and Law
(Richard R. Sharp, Gary Marchant, & Jamie A Grodsky eds., Johns Hopkins University Press 2008).
QH438.7 .G462 2008
Setting Air Quality Standards in the Post-genomic Era
, in
Genomics and Environmental Regulation : Science, Ethics, and Law
(Richard R. Sharp, Gary Marchant, & Jamie A Grodsky eds., Johns Hopkins University Press 2008).
QH438.7 .G462 2008
Gary Marchant & Andrew Askland,
Genetic Data and Toxic Torts: Intimations of Statistical Reductionism
, in
Genomics and Environmental Regulation : Science, Ethics, and Law
(Richard R. Sharp, Gary E. Marchant, Jamie A. Grodsky eds., John Hopkins University Press).
QH438.7 .G462 2008
Toxicogenomics and Environmental Regulation
, in
Genomics and Environmental Regulation : Science, Ethics, and Law
(Richard R. Sharp, Gary Marchant, & Jamie A Grodsky eds., Johns Hopkins University Press 2008).
QH438.7 .G462 2008